AU2023250008A1 - Crystalline forms of a macrocyclic peptide antibiotic - Google Patents

Crystalline forms of a macrocyclic peptide antibiotic Download PDF

Info

Publication number
AU2023250008A1
AU2023250008A1 AU2023250008A AU2023250008A AU2023250008A1 AU 2023250008 A1 AU2023250008 A1 AU 2023250008A1 AU 2023250008 A AU2023250008 A AU 2023250008A AU 2023250008 A AU2023250008 A AU 2023250008A AU 2023250008 A1 AU2023250008 A1 AU 2023250008A1
Authority
AU
Australia
Prior art keywords
theta
wavenumbers
xrpd
absorption bands
atr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023250008A
Other languages
English (en)
Inventor
Ralph Diodone
André Egli
Dennis Dimo ENKELMANN
Michel Dominik LINDEMER
Valentin Andreas STADELMANN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2023250008A1 publication Critical patent/AU2023250008A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2023250008A 2022-04-07 2023-04-05 Crystalline forms of a macrocyclic peptide antibiotic Pending AU2023250008A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22167057.3 2022-04-07
EP22167057 2022-04-07
PCT/EP2023/058906 WO2023194418A1 (en) 2022-04-07 2023-04-05 Crystalline forms of a macrocyclic peptide antibiotic

Publications (1)

Publication Number Publication Date
AU2023250008A1 true AU2023250008A1 (en) 2024-10-03

Family

ID=81448543

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023250008A Pending AU2023250008A1 (en) 2022-04-07 2023-04-05 Crystalline forms of a macrocyclic peptide antibiotic

Country Status (10)

Country Link
EP (1) EP4504749A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025511869A (cg-RX-API-DMAC7.html)
KR (1) KR20240169690A (cg-RX-API-DMAC7.html)
CN (1) CN118974073A (cg-RX-API-DMAC7.html)
AU (1) AU2023250008A1 (cg-RX-API-DMAC7.html)
CA (1) CA3255726A1 (cg-RX-API-DMAC7.html)
IL (1) IL315686A (cg-RX-API-DMAC7.html)
MX (1) MX2024012228A (cg-RX-API-DMAC7.html)
TW (1) TW202404991A (cg-RX-API-DMAC7.html)
WO (1) WO2023194418A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026154152A1 (en) * 2025-01-20 2026-07-23 F. Hoffmann-La Roche Ag Pharmaceutical compositions comprising an antibiotic macrocyclic peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11819532B2 (en) 2018-04-23 2023-11-21 Hoffmann-La Roche Inc. Peptide macrocycles against Acinetobacter baumannii

Also Published As

Publication number Publication date
CN118974073A (zh) 2024-11-15
CA3255726A1 (en) 2023-10-12
EP4504749A1 (en) 2025-02-12
IL315686A (en) 2024-11-01
MX2024012228A (es) 2024-11-08
WO2023194418A1 (en) 2023-10-12
TW202404991A (zh) 2024-02-01
KR20240169690A (ko) 2024-12-03
JP2025511869A (ja) 2025-04-16

Similar Documents

Publication Publication Date Title
AU2009245817B2 (en) Organic compounds
EP2753613B1 (en) Derivatives of xanthone compounds
CN107056813B (zh) 德罗格韦钠盐的晶型及其制备方法
CN105061358A (zh) 甲基锍氯化物结晶水合物
EP4504749A1 (en) Crystalline forms of a macrocyclic peptide antibiotic
ES2553165T3 (es) Preparación de un antibiótico cristalino de ácido fusídico
HK40114674A (en) Crystalline forms of a macrocyclic peptide antibiotic
CN110938114A (zh) 一类万古霉素硫鎓衍生物、其制备方法、药物组合物和用途
NZ577978A (en) The fumarate salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
CN114466652A (zh) (r)-2-[2-氨基-3-(吲哚-3-基)丙酰基氨基]-2-甲基丙酸的新型多晶型物晶型及其用途
CZ217694A3 (en) 3/2 hydrate and anhydrate of 7-/(7-(s)-amino-5-azaspiro/2.4/heptan-5-yl/-8-chloro-6-fluoro-1-/(1r,2s) 2-fluorocyclopropyl/-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, processes of selective production of 3/2 hydrate, crystals thereof and antibacterial agents based thereon
US20250171428A1 (en) Crystalline forms of 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4- yl)methoxy)- n -(tetrahydrapyran-4-yl)pyridazine-3-carboxamide
US20110144154A1 (en) Salts of 2-Substituted Quinolines
HK40114727A (en) Crystalline forms of 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)-n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide